Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-DCLK1 Antibody (R1D47)

Catalog #:   RHA40702 Specific References (36) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IHC, WB
Accession: O15075
Overview

Catalog No.

RHA40702

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Doublecortin-like and CAM kinase-like 1, DCAMKL1, KIAA0369, Doublecortin-like kinase 1, DCLK1, Doublecortin domain-containing protein 3A, Serine/threonine-protein kinase DCLK1, DCDC3A

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O15075

Applications

FCM, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1D47

Data Image
  • Western blot
    Western blot analysis of DCAMKL1 expression in SH-SY5Y cell lysate;.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
References

Clinical significance of "S" isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody., PMID:40109216

DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target., PMID:40056091

Pleiotropic effects of DCLK1 in cancer and cancer stem cells., PMID:36250024

Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model., PMID:36040667

Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles., PMID:35738074

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis., PMID:35717205

Dietary antigens suppress the proliferation of type 2 innate lymphoid cells by restraining homeostatic IL-25 production., PMID:35523930

Duodenal cholinergic tuft cell number is increased in functional dyspepsia., PMID:35388579

Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer., PMID:34958000

Recent advances in drug delivery systems for targeting cancer stem cells., PMID:33532180

Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment., PMID:33348546

Morphological characterization of brush cells in the rat trachea., PMID:32933721

The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer., PMID:32671503

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis., PMID:32203220

DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers., PMID:31878090

Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment., PMID:31296243

Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma., PMID:30814526

Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1., PMID:30174443

Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells., PMID:29604293

Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer., PMID:29577277

Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity., PMID:28570279

A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy., PMID:28414327

Tyrosine Phosphorylation of an Actin-Binding Protein Girdin Specifically Marks Tuft Cells in Human and Mouse Gut., PMID:28375676

A novel double-targeted nondrug delivery system for targeting cancer stem cells., PMID:27994463

Enhanced expression of the stemness-related factors OCT4, SOX15 and TWIST1 in ectopic endometrium of endometriosis patients., PMID:27881125

Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies., PMID:27470117

[Cancer stemness and circulating tumor cells]., PMID:25985635

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma., PMID:25605241

DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinoma., PMID:25283374

Characterization of anoikis-resistant cells in mouse colonic epithelium., PMID:23629020

Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin., PMID:23374535

Doublecortin and doublecortin-like are expressed in overlapping and non-overlapping neuronal cell population: implications for neurogenesis., PMID:22605579

Gastric tuft cells express DCLK1 and are expanded in hyperplasia., PMID:21688022

Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells., PMID:21183658

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas., PMID:20522640

DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization., PMID:11124993

Datasheet

Document Download

Anti-DCLK1 Antibody (R1D47).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-DCLK1 Antibody (R1D47) [RHA40702]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only